Login / Signup

Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses.

Katerina PantavouAnneza I YiallourouDaniele PiovaniDespo EvripidouSilvio DaneseLaurent Peyrin-BirouletStefanos BonovasGeorgios K Nikolopoulos
Published in: United European gastroenterology journal (2019)
Biologics and tofacitinib are efficacious and safe for treating UC. These findings can support clinical decision-making.
Keyphrases
  • ulcerative colitis
  • meta analyses
  • rheumatoid arthritis
  • decision making
  • systematic review
  • randomized controlled trial
  • high intensity
  • drug induced